Page last updated: 2024-09-04

cpi 1189 and AIDS Dementia Complex

cpi 1189 has been researched along with AIDS Dementia Complex in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's3 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Clifford, DB; Cohen, BA; Ellis, RJ; Kieburtz, K; Letendre, S; Marder, K; Marra, CM; McArthur, JC; McDermott, MP; Schifitto, G1
Arendash, GW; Bjugstad, KB; Flitter, WD; Garland, WA; Kirstein, CL; Philpot, RM1
Flitter, WD; Garland, WA; Irwin, I; Kusdra, L; Pulliam, L; Rempel, H1

Trials

1 trial(s) available for cpi 1189 and AIDS Dementia Complex

ArticleYear
A randomized clinical trial of CPI-1189 for HIV-associated cognitive-motor impairment.
    Neurology, 2002, Nov-26, Volume: 59, Issue:10

    Topics: Adult; AIDS Dementia Complex; Antioxidants; Biomarkers; Butanes; Cognition Disorders; Double-Blind Method; Female; Humans; Male; Movement Disorders; Neurologic Examination; Neuropsychological Tests; Nitrogen Oxides; Patient Compliance; Psychometrics; Treatment Outcome; Tumor Necrosis Factor-alpha

2002

Other Studies

2 other study(ies) available for cpi 1189 and AIDS Dementia Complex

ArticleYear
CPI-1189 prevents apoptosis and reduces glial fibrillary acidic protein immunostaining in a TNF-alpha infusion model for AIDS dementia complex.
    Journal of neurovirology, 2000, Volume: 6, Issue:6

    Topics: Administration, Oral; AIDS Dementia Complex; Animals; Antioxidants; Apoptosis; Astrocytes; Basal Ganglia; Blood-Brain Barrier; Butanes; Corpus Callosum; Depression, Chemical; Disease Models, Animal; Drug Evaluation, Preclinical; Glial Fibrillary Acidic Protein; Gliosis; Hydroxyl Radical; Immunoglobulin G; Injections, Intraventricular; Lipid Peroxidation; Male; Neocortex; Neuroprotective Agents; Nitrogen Oxides; Oxidative Stress; Rats; Rats, Sprague-Dawley; Salicylates; Septum Pellucidum; Thiobarbituric Acid Reactive Substances; Tumor Necrosis Factor-alpha

2000
CPI-1189 attenuates effects of suspected neurotoxins associated with AIDS dementia: a possible role for ERK activation.
    Brain research, 2001, Mar-02, Volume: 893, Issue:1-2

    Topics: AIDS Dementia Complex; Apoptosis; Brain; Butanes; Cells, Cultured; Culture Media, Conditioned; Enzyme Activation; Enzyme Inhibitors; Flavonoids; HIV Envelope Protein gp120; Humans; Macrophages; Mitogen-Activated Protein Kinases; Monocytes; Necrosis; Neurons; Neurotoxins; NF-kappa B; Nitrogen Oxides; Phosphorylation; Protein Transport; Quinolinic Acid; Tumor Necrosis Factor-alpha

2001